Stay updated on Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check35 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check78 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes a new study on Clear Cell Renal Cell Carcinoma, while significant details about the previous study and its methodology have been removed.SummaryDifference12%
- Check85 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.